Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price61.10 USD
Fair value64.98
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Accumulation58.67+4.1% to today ✓
2026-08-26Read Distribution63.62-4.0% to today ✓
2026-07-02Read Markup66.13-7.6% to today
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
CTS Corporation holds its Accumulation at $61.10. The statistical read favours the sellers, held for 18 days.
As held on the ledger · 2026-10-06
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 18 days
Price at the screen
$61.10
Valuation
25.56 trailing · 21.31 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.99
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
10.83%
Below 33%
Interest-bearing debt is just 10.8% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
22.29%
Below 49%
Money owed to the company is 22.3% of assets, under the 49% limit.
Pass
Revenue purity
0.39%
Below 5%
Only 0.4% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
CTS clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 11%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-10-07. It updates when the underlying figures move, and past reads are kept below.
Fair value range in USD, drawn from the 2026-10-06 screen. The gold marker is the market price at the same screen. A 6.3% margin of safety to the base estimate.
Third-party analyst targets: 3 covering, consensus Strong Buy. The average target sits +10% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Sensors maker sits right at its fair value
Every time a car accelerates or a factory machine filters interference, CTS components sit inside the system doing quiet work. The business grows revenue at 11 percent with a 12 percent profit margin and 13 percent ROE, yet the shares trade at a 2 percent premium to our fair value of 58 dollars against the current 59.40 dollar price. With a forward multiple of 20.6 times and only one analyst covering the name, nothing in the numbers creates a clear entry point.
We therefore pass. The ethical screen clears without issue and the underlying demand for sensors and filters looks steady, but the absence of any margin of safety removes the margin for error that our approach requires.
Risks centre on modest returns on equity and unknown competitive protection in a sector that can swing with industrial cycles. Currency moves across North America, Europe and Asia add another layer of uncertainty that could quickly compress the thin valuation buffer that exists today. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CTS trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 7.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (1 analysts) rates it none, with a mean price target of $58.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 7.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (1 analysts) rates it none, with a mean price target of $58.
2026-07-25Markup$59.40-10.2%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 10.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (1 analysts) rates it none, with a mean price target of $58.
2026-07-18Markup$66.13+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 37% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 52%. Our forward projection puts the odds of a 10% gain over the next month near 22%. The street (1 analysts) rates it none, with a mean price target of $58.
2026-07-03Markup$66.13+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Markup$66.13Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
